Exscientia Plc Asset Turnover Ratio (EXAI), as of third quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Exscientia Plc  (NASDAQ: EXAI)
 

Exscientia Plc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Exscientia Plc's asset turnover ratio has remained unchanged compare to previous quarter at 0.04 in the third quarter (Sep 30 2024)

Within sector 74 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2024 compared to the preceding quarter from 0 to 4535.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EXAI Asset Turnover Ratio (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Asset Change -23.09 % -25.85 % -17.05 % -10.29 % -15.58 %
Y / Y Revenue Change 70.39 % -20.35 % -62.31 % 51.77 % -58.07 %
Asset Turnover Ratio (TTM) 0.04 0.04 0.04 0.04 0.03
EXAI's Total Ranking # 4535 # 0 # # #
Seq. Asset Change -0.38 % -14.98 % -3.14 % -6.25 % -3.95 %
Seq. Revenue Change 14.98 % 84.77 % -73.17 % 198.91 % -46.25 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 75
Healthcare Sector # 669
Overall Market # 4535

Asset Turnover Ratio Statistics
High Average Low
0.04 0.04 0.04
(Dec 31 2022)   (Dec 31 2023)




EXAI Company Profile • Back to EXAI Efficiency Comparisons • Compare EXAI Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2024 Assets at quarter ending Sep 30 2024
Arvinas Inc   0.13 $ 161.100  Millions$ 1,240.975  Millions
Anaptysbio Inc   0.13 $ 57.172  Millions$ 444.755  Millions
Skinvisible Inc   0.13 $ 0.020  Millions$ 0.157  Millions
Pavmed Inc   0.12 $ 4.383  Millions$ 35.084  Millions
Tff Pharmaceuticals Inc  0.12 $ 1.161  Millions$ 9.447  Millions
Xencor Inc  0.12 $ 108.666  Millions$ 925.627  Millions
Zymeworks Inc   0.12 $ 62.199  Millions$ 534.355  Millions
Inspiremd Inc   0.12 $ 5.676  Millions$ 48.953  Millions
Cyclo Therapeutics Inc   0.11 $ 0.871  Millions$ 7.596  Millions
Hcw Biologics Inc   0.11 $ 3.215  Millions$ 28.079  Millions
Tango Therapeutics Inc   0.11 $ 43.384  Millions$ 385.664  Millions
Zomedica Corp   0.11 $ 25.965  Millions$ 232.724  Millions
Pacific Biosciences Of California Inc   0.11 $ 171.656  Millions$ 1,593.869  Millions
Kymera Therapeutics Inc   0.11 $ 87.563  Millions$ 826.218  Millions
Alector Inc   0.10 $ 61.508  Millions$ 586.018  Millions
Longeveron Inc   0.10 $ 1.852  Millions$ 17.769  Millions
Tvardi Therapeutics Inc   0.10 $ 8.686  Millions$ 84.942  Millions
Iovance Biotherapeutics inc   0.10 $ 90.858  Millions$ 901.405  Millions
Foxo Technologies Inc   0.10 $ 1.341  Millions$ 13.324  Millions
Tonix Pharmaceuticals Holding Corp   0.10 $ 11.291  Millions$ 113.774  Millions
Dar Bioscience Inc   0.10 $ 1.881  Millions$ 18.990  Millions
Igc Pharma Inc   0.10 $ 1.183  Millions$ 12.011  Millions
Mangoceuticals Inc   0.10 $ 0.755  Millions$ 7.846  Millions
Recursion Pharmaceuticals Inc   0.10 $ 65.184  Millions$ 678.477  Millions
Bluebird Bio Inc   0.09 $ 53.120  Millions$ 565.223  Millions
Xoma Royalty Corporation  0.09 $ 21.606  Millions$ 230.085  Millions
Dbv Technologies S a   0.09 $ 12.514  Millions$ 141.610  Millions
C4 Therapeutics Inc   0.09 $ 33.668  Millions$ 382.994  Millions
Crispr Therapeutics Ag  0.09 $ 202.829  Millions$ 2,316.143  Millions
Co diagnostics Inc   0.09 $ 7.321  Millions$ 83.769  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.